Proteomic Approach for Diagnostic Applications in Head and Neck Cancer
No involved investigator sites defined.
To evaluate the test characteristics of a panel of biomarkers for identifying patients with early stage head and neck squamous cell carcinoma (HNSCC). The primary endpoints are sensitivity, specificity and accuracy of the marker panel. This study of the test characteristics of a modeling strategy for diagnosing HNSCC uses a case-control design, with several types of cases and several types of controls.
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.